Moderna is soaring after promising results for its cancer vaccine. Plus, Target may be victim to profit-taking.

ST. LOUIS, Aug. 19, 2026 (GLOBE NEWSWIRE) -- ST. LOUIS, MO — August 2026 — ButcherJoseph & Co. (“ButcherJoseph”), a leading middle-market investment bank specializing in M&A and employee ownership transactions, is pleased to announce that it served as financial advisor to Southern Shade Tree Co., In

The sharp-elbowed billionaire is remaking Frasers with acquisitions including Harvey Nichols, but the stock market remains wary

FORM 8.3

SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that Cameron Perrett joined the firm as Managing Director. SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today

FORM 8.3

Shares of Moderna and Merck soared on Wednesday morning after a study showed that a vaccine they produced had promising results when it comes to fighting skin cancer. A late-stage trial showed that the mRNA vaccine helped reduce the recurrence of melanoma. Sam Fazeli of Bloomberg Intelligence has mo

Strategic Value Partners is considering a sale of APCOA Parking Holdings, which could fetch €2 billion ($2.3 billion) to €2.5 billion, people familiar with the matter said.

The candidate is a combination of an mRNA therapeutic vaccine and Merck’s cancer drug Keytruda.

Home Bancorp SEVP John Zollinger IV sells $53,760 in shares